Please assess the completion status of the following clinical trial:

Trial Title: Pilot Efficacy Study of T2000 in Myoclonus Dystonia

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients should meet diagnostic criteria for M-D based on the following criteria:~  * myoclonus is the primary feature; focal or segmental dystonia of any severity may also be present~ * symptoms began by age 20~ * a familial pattern should be present~ * neurological history should not be suggestive of a different neurological condition~ * investigations such as imaging, EEG and evoked potential tests should be normal~* Patients will be eligible for this study if they are symptomatic on their current treatment, cannot tolerate current therapies, or are treatment naïve patients who have been explained treatment alternatives.~Exclusion Criteria:~* Patients adequately controlled without side effects on a current M-D treatment~* Current treatment with a barbiturate such as phenobarbital or primidone~* Pregnant patients or patients who may become pregnant during the study~* Patients who must take medications that alter liver metabolism as well as patients with liver disease or coagulation disorders~* Patients with seizure disorders~* Patients with a history of allergy or hypersensitivity reaction to barbiturates or other related medications, such as phenobarbital or phenytoin~* Patient with significant general medical or clinical laboratory abnormalities

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): T2000

Based on this trial design, predict the completion outcome and termination type (if applicable).